Evidence map›Paper›PMID 35768121›Full record

ArticleBMJ open2022

Experiences of and response to the COVID-19 pandemic at private retail pharmacies in Kenya: a mixed-methods study.

Peter Mwangi Mugo, Audrey Mumbi, Daniella Munene, Jacinta Nzinga, Sassy Molyneux, Edwine Barasa, PSK COVID-19 Response Taskforce

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Peter Mwangi MugoHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya PMugo@kemri-wellcome.org.ORCID 0000-0002-1808-3292
Audrey MumbiHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Daniella MuneneCEO Office, Pharmaceutical Society, Kilifi, Kenya.
Jacinta NzingaHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.ORCID 0000-0001-8394-8857
Sassy MolyneuxHealth Systems and Research Ethics Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Edwine BarasaHealth Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
PSK COVID-19 Response Taskforce
Kenya Medical Research Institute · KE

Funding

Wellcome Trust 077092
6 · The paper itself

Abstract

objectivesTo assess experiences of and response to the COVID-19 pandemic at community pharmacies in Kenya. DESIGN, SETTING AND

participantsThis was a mixed-methods study conducted from November 2020 to April 2021, targeting service providers in three counties (Nairobi, Mombasa and Kisumu), selected purposively to represent the main urban centres; pharmacies were selected randomly from a list of licensed pharmacies.

resultsOf 195 sampled pharmacies, 108 (55%) completed a questionnaire and 103 (53%) received a simulated client call; 18 service providers were interviewed. The initial weeks of the pandemic were characterised by fear and panic among service providers and a surge in client flow. Subsequently, 65 (60%) of 108 pharmacies experienced a dip in demand to below prepandemic levels and 34 (31%) reported challenges with unavailability, high price and poor quality of products. Almost all pharmacies were actively providing preventive materials and therapies; educating clients on prevention measures; counselling anxious clients; and handling and referring suspect cases. Fifty-nine pharmacies (55% (95% CI 45% to 65%)) reported receiving a client asking for COVID-19 testing and a similar proportion stated they would support pharmacy-based testing if implemented. For treatment of simulated clients, most pharmacies (71%, 73 of 103) recommended alternative therapies and nutritional supplements such as vitamin C; the rest recommended conventional therapies such as antibiotics. While 52 (48%) of 108 pharmacies had at least one staff member trained on COVID-19, a general feeling of disconnection from the national programme prevailed.

conclusionsPrivate pharmacies in Kenya were actively contributing to the COVID-19 response, but more deliberate engagement, support and linkages are required. Notably, there is an urgent need to develop guidelines for pharmacy-based COVID-19 testing, a service that is clearly needed and which could greatly increase test coverage. Pharmacy-based COVID-19 programmes should be accompanied with implementation research to inform current and future pandemic responses.

Indexed as

COVID-19PharmaciesCOVID-19 TestingHumansKenyaPandemicsCOVID-19PRIMARY CAREPublic healthPUBLIC HEALTHQUALITATIVE RESEARCHQuality in health care

Identifiers

PMID35768121
PMCPMC9240447
OpenAlexW4283687520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.